Skip to main content

EU AI Act Compliance for Healthcare AI

EU AI Act compliance guide for healthcare and medical device AI systems, covering high-risk classification and MDR interplay.

Healthcare AI systems face dual compliance frameworks: the EU AI Act and Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR).

If your AI system is a safety component of, or classifies as, a medical device under MDR/IVDR, it automatically qualifies as high-risk under the EU AI Act. This means combined conformity assessment, integrated risk management, and notified body involvement.

How Healthcare AI Gets Classified

Most diagnostic and clinical decision support AI systems fall under Annex I of the EU AI Act by virtue of MDR/IVDR classification. Class IIa devices and above typically require notified body conformity assessment, triggering automatic high-risk status.

Risk Management is Non-Negotiable

Healthcare AI risk management must be integrated with ISO 14971 (MDR standard). Article 9 of the EU AI Act requires documented risk identification, mitigation, and residual risk acceptance by qualified personnel.

Human Oversight Prevents Automation Bias

Article 14 mandates meaningful human oversight for high-risk AI. In healthcare, clinicians must understand AI recommendations, be trained to override them, and have authority to do so—especially for life-critical decisions.

Healthcare AI Categories

Diagnostic Imaging AI

Radiology, pathology, and medical imaging analysis. These are almost always Class IIa or higher under MDR, requiring notified body involvement and full EU AI Act high-risk compliance.

Clinical Decision Support Systems

AI that assists clinicians in diagnosis or treatment recommendations. Classification depends on intended use; many qualify as Class IIb or IIa under MDR, triggering high-risk EU AI Act obligations.

AI-Based Triage and Early Warning Systems

Predictive AI for patient prioritization or deterioration alerts. Often Class IIa under MDR if they influence clinical decisions; subject to high-risk conformity assessment under the EU AI Act.

EU AI Act × MDR/IVDR Overlap

Healthcare AI conformity assessment can be streamlined by combining EU AI Act and MDR/IVDR procedures with a single notified body, provided the body is qualified for both regimes.

Combined Conformity Assessment

A single notified body can assess both MDR and EU AI Act requirements simultaneously. This reduces duplication and timelines when your AI system qualifies as high-risk under both.

Risk Management Integration

EU AI Act risk management (Article 9) must align with MDR risk management (ISO 14971). Many organizations integrate both frameworks into a single risk analysis and mitigation plan.

Technical Documentation Alignment

MDR technical documentation requirements substantially overlap with EU AI Act technical file requirements (Article 11). Single documentation can satisfy both.

IVDR Considerations

In Vitro Diagnostic devices under IVDR 2017/746 follow the same high-risk classification logic as MDR. AI-based pathology or laboratory analysis systems must comply with both IVDR and the EU AI Act.

Real-World Healthcare AI Examples

AI Radiology Diagnostic Tool

A deep learning system that analyzes X-rays and CT scans to detect fractures, lesions, or abnormalities.

MDR classification: typically Class IIa (if notified body involvement); EU AI Act: high-risk. Requires risk management per ISO 14971, clinical validation data, human-in-the-loop oversight protocols, and cybersecurity documentation.

AI-Based Sepsis Prediction System

An algorithm that predicts sepsis risk based on vital signs, lab values, and patient history to trigger early intervention.

MDR: Class IIa for decision support; EU AI Act: high-risk. Requires clinical accuracy validation, human oversight by trained clinicians, risk management for automation bias, and audit logging.

AI Pathology Slide Analysis

Digital pathology system using AI to analyze microscopy images for cancer, infection, or tissue classification.

IVDR classification: typically Class D (in vitro diagnostic); EU AI Act: high-risk. Requires analytical and clinical validation, integration with pathologist workflows, and traceability documentation.

AI Triage and Prioritization Tool

An AI system that prioritizes emergency department patients based on acuity and predicted outcomes.

MDR: Class IIa as clinical decision support; EU AI Act: high-risk. Requires fairness and bias testing, documented thresholds for clinician override, and performance monitoring across patient populations.

Healthcare AI Compliance Checklist

Article 9
euAiAct.industryHealthcare.checklist1Title

euAiAct.industryHealthcare.checklist1Desc

Article 10
euAiAct.industryHealthcare.checklist2Title

euAiAct.industryHealthcare.checklist2Desc

Article 12
euAiAct.industryHealthcare.checklist3Title

euAiAct.industryHealthcare.checklist3Desc

Article 13
euAiAct.industryHealthcare.checklist4Title

euAiAct.industryHealthcare.checklist4Desc

Article 14
euAiAct.industryHealthcare.checklist5Title

euAiAct.industryHealthcare.checklist5Desc

Article 15
euAiAct.industryHealthcare.checklist6Title

euAiAct.industryHealthcare.checklist6Desc

Article 17
euAiAct.industryHealthcare.checklist7Title

euAiAct.industryHealthcare.checklist7Desc

Article 72
euAiAct.industryHealthcare.checklist8Title

euAiAct.industryHealthcare.checklist8Desc

Key Compliance Deadlines

Immediately: MDR Implementation

MDR already in force. Devices placed on market today must comply. EU AI Act enforcement for high-risk healthcare AI begins 2 December 2027 for Annex III systems, or 2 August 2028 for AI that is a safety component of a medical device regulated under MDR/IVDR (the Annex I route).

2 August 2028: High-Risk AI Enforcement (Medical Devices)

Deadline for EU AI Act compliance for existing high-risk systems. Healthcare AI systems with MDR classification as Class IIa or above must be compliant by this date.

2028 Onwards: Ongoing Compliance and Audits

Post-enforcement, expect notified body audits, market surveillance, and periodic technical file updates as clinical evidence and regulations evolve.

Enforcement and Penalties

Non-compliance carries fines up to €15 million or 3% of global annual turnover (whichever is higher). Healthcare regulators (notified bodies, competent authorities) conduct ongoing surveillance. Breaches can result in market withdrawal, recalls, or suspension of CE marking.

Frequently Asked Questions

Related Requirements and Articles


How Scanara Helps

Scanara automates EU AI Act compliance from code to dossier. Connect your GitHub repos and get compliance reports in minutes.